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ABSTRACT
The Mouse Phenome Database (MPD; http://
www.jax.org/phenome) is an open source, web-
based repository of phenotypic and genotypic data
on commonly used and genetically diverse inbred
strains of mice and their derivatives. MPD is also a
facility for query, analysis and in silico hypothesis
testing. Currently MPD contains about 1400 pheno-
typic measurements contributed by research teams
worldwide, including phenotypes relevant to human
health such as cancer susceptibility, aging, obesity,
susceptibility to infectious diseases, atherosclero-
sis, blood disorders and neurosensory disorders.
Electronic access to centralized strain data enables
investigators to select optimal strains for many
systems-based research applications, including
physiological studies, drug and toxicology testing,
modeling disease processes and complex trait
analysis. The ability to select strains for specific
research applications by accessing existing pheno-
type data can bypass the need to (re)characterize
strains, precluding major investments of time and
resources. This functionality, in turn, accelerates
research and leverages existing community
resources. Since our last NAR reporting in 2007,
MPD has added more community-contributed data
covering more phenotypic domains and implemen-
ted several new tools and features, including a new
interactive Tool Demo available through the MPD
homepage (quick link: http://phenome.jax.org/phe
nome/trytools).
INTRODUCTION
The laboratory mouse is an invaluable model organism for
investigating the genetic basis of human disease. Studies
have demonstrated the eﬃcacy of comparative mouse–
human genomics to identify novel mechanisms of human
disease progression, underscoring the need to make mouse
strain data widely available for community access.
Using inbred strain data for integrative studies leverages
their ﬁxed genotypes and expands their utility to deter-
mine molecular relationships between disease and asso-
ciated risk factors.
The Mouse Phenome Project was launched as an inter-
national collaboration to complement the mouse genome
sequencing eﬀort and provide a research resource and
integral tool for complex trait analysis (1). This powerful
approach, termed phenomics, captures complexities of
entire biological pathways that are not accessible through
conventional approaches. A central database was built to
support the Project and provide a repository for the large
amounts of data collected. The database, called the Mouse
Phenome Database (MPD; www.jax.org/phenome), has
been publicly available since 2001 (2). MPD is a grant-
supported eﬀort with three full-time staﬀ members head-
quartered at The Jackson Laboratory (JAX), a non-proﬁt
biomedical research institute with a focus on the mouse as
a model for understanding human biology and disease
(http://www.jax.org).
The Mouse Phenome Project promotes and facilitates
strain surveys that follow a set of recommendations pro-
posed by members of the research community to standar-
dize testing across laboratories and over time, and
ultimately to maximize data reproducibility and value.
A set of diverse inbred mouse strains was carefully
chosen for systematic phenotyping to generate the build-
ing blocks of the phenome of the laboratory mouse. The
Project is open to researchers with expertise in any biome-
dically-relevant ﬁeld of study. Strain characteristics data
are received from members of the scientiﬁc community
and added to the MPD standardized framework, provid-
ing users a platform for data exploration, analysis and
hypothesis testing. Project recommendations, priority
strains and data submission guidelines are accessible
through the MPD homepage.
The ability of investigators to use MPD to ﬁnd causal
genes and biomarkers of human disease will be signiﬁ-
cantly enhanced by the capacity to integrate human data
with comprehensive information on the laboratory mouse.
International eﬀorts are underway to address integration
*To whom Correspondence should be addressed. Tel: +1 207 288 6016; Fax: +1 207 288 6079; Email: molly.bogue@jax.org
 2008 The Author(s)
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/
by-nc/2.0/uk/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.issues for several public mouse resources holding
phenotypic data (3), including Europhenome at Harwell
(UK), PhenoSITE at Riken (Japan) and MPD.
Discussions are in progress to coordinate data formats
and reporting standards that ensure interoperability
across databases. We have also been involved in the devel-
opment of minimum information for mouse phenotyping
procedures (MIMPP; www.interphenome.org) as part
of the larger community-wide eﬀort for minimum infor-
mation for biological and biomedical investigations
(MIBBI) (14) that fosters coordination of minimum infor-
mation checklists such as minimum information about a
microarray experiment (MIAME). These checklists ensure
adequate descriptions about the biological material being
tested (or used for testing) and the assays employed
for measuring biological or behavioral manifestations
(traits). Until community standards are in place for
reporting phenotypic data, we will continue using the
deﬁnitions adopted when MPD was launched in 2001
(Table 1).
DATA IN MPD
Our last NAR update was in 2007 (5). Most of the discus-
sion points, ﬁgures and URLs set forth there are still cur-
rent. Before presenting our recent updates, we will review
some fundamental points about MPD. Every MPD pro-
ject has a dataset and detailed protocols, health status and
environmental parameters of the test animals, and any
other information essential to understand and evaluate
the data (Table 1). MPD is also a repository for protocol
information where a library of procedures and assays are
maintained so that others in the community may beneﬁt
from their use. Most phenotypic datasets in MPD are in
strain survey format. For example, an expert in lipid meta-
bolism participating in the Project and following Project
recommendations might take readings on 10 females and
10 males of 40 strains and submit the individual animal
data in a spreadsheet having one row per mouse and mul-
tiple columns for various lipid measurements. We would
then annotate and format the data to meet MPD stan-
dards. Each measurement is classiﬁed and integrated in
the MPD phenotype category structure. We compute sum-
mary statistics, where our unit of analysis is an MPD
measurement with strain (by sex) being our analysis
group (we do not combine male and female data nor do
we combine data from diﬀerent MPD measurements).
Individual animal data and summary statistics are avail-
able for downloading as well as protocols and other meta-
data. To identify possible biological correlations (related
phenotypes may indicate common genes or pathways), we
further analyze each measurement by regression analysis
with every other measurement currently in the database
and store the results to support queries based on measure-
ment correlations (see below) (2). In addition to phenoty-
pic data, strain genotypes are collected and stored in MPD
so that phenotypic and genotypic data can be juxtaposed,
facilitating the ability to determine how allele-speciﬁc var-
iations translate to diﬀerences in mouse phenotype.
Current contents
At the present time MPD contains around 1400 phenoty-
pic measurements and 740 million single nucleotide
polymorphism (SNP) allele calls. Over 600 strains of
mice are represented in MPD where phenotypic and/or
genotypic data are available (most of the data are for
MPD priority strains and their derivatives). Around 200
people are currently registered as principal investigators of
MPD projects (phenotyping and genotyping), represent-
ing 130 institutions in 12 countries, and supported by
60 funding agencies and research foundations world-
wide. Phenotypic measurements are from 75 investiga-
tor-contributed projects (20 other projects are
pending), with coverage in a number of important areas
(summarized in Table 2). Several large phenotyping initia-
tives utilize MPD as the oﬃcial repository for their strain
survey data, including the Jackson Aging Center (Nathan
Shock Center of Excellence in the Basic Biology of Aging)
and the Heart, Lung, Blood and Sleep Disorders Center
(NHLBI Program for Genomic Applications) (6).
Phenotypic data currently available can be classiﬁed as
baseline (72%), longitudinal aging data (14%), or con-
trolled studies of intervention eﬀects (14%) such as admin-
istering drugs or high-fat diet, or exposure to toxins or
pathogens. Each measurement contains data from multi-
ple strains of mice with as many as 60 strains tested (the
average per measurement is 20 strains). Most projects
involve both sexes (84%) and use MPD priority strains
(82%). The remaining 18% are special strain panels where
the progenitors are often MPD priority strains. Analysis
tools for phenotypic data are available in the MPD
Toolbox depicted in Figure 1. To see how these tools
work, see the interactive Tool Demo available through
the MPD homepage (quick link: http://phenome.jax.org/
phenome/trytools).
Genomic characterization of mouse strains is currently
supported in MPD by way of SNP data. Copy number
variant (CNV) data will be added in the future. SNP data-
sets are supplied by investigators (or institutions) either
directly or as freely available data downloads. The MPD
SNP collection currently includes 8+million unique geno-
mic locations for 16 strains in our high-density merged
dataset (about 3.5 SNP locations per 1kb) and lesser
amounts of SNP data for approximately 125 additional
strains plus 7 recombinant inbred (RI) strain panels.
Overall, there are 18 SNP data sources represented in
MPD, including SNPs from Broad, Celera, Perlegen
(NIEHS), Wellcome Trust, Genomics Institute of the
Novartis Research Foundation (GNF), and The Jackson
Laboratory. To provide maximal utility for diﬀerent
research applications, MPD consolidates SNPs from mul-
tiple sources based on SNP density and the complement of
strains assayed. Currently there are ﬁve datasets with four
degrees of SNP density (high, as deﬁned above; to very low
2000 SNPs per entire genome). SNP and gene annota-
tions from external resources such as Mouse Genome
Informatics (MGI; http://www.informatics.jax.org) (7),
NCBI dbSNP (http://www.ncbi.nlm.nih.gov/projects/
SNP), (8) and Ensembl (http://www.ensembl.org) (9) are
part of the merge operation. NCBI dbSNP also provides
Nucleic Acids Research, 2009,Vol. 37,Database issue D721Table 1. MPD Deﬁnitions
Term Deﬁnition Relationships Comments
MPD Project Entity that logically binds a
scientiﬁc investigation’s unique
dataset, protocols and other
documentation necessary to
evaluate and use the data.
An MPD project has only one
primary dataset and one
protocol.
A project usually represents the characteri-
zation of a cohort of animals tested for
multiple traits; a project can stand alone
in that the source (submitting investiga-
tor), all the data, and all the information
needed to understand the data are bound.
MPD Protocol Entity that binds one or more
speciﬁc procedures, contains
information about test animals,
and their environment, anesthe-
sia, experimental design, inter-
ventions, workﬂow and other
overarching concepts that apply
to one or more component
procedures of the protocol.
There is one protocol for every
project. A protocol may contain
more than one procedure.
An intervention is a controlled perturbation
(or treatment) that is part of the study,
such as high-fat diet, ethanol in drinking
water or toxin exposure. For every
intervention, there should be a control
(baseline).
Procedure Detailed information about an
experimental method, con-
taining descriptions about
equipment, reagents, solution
preparation, safety issues,
special deﬁnitions, formulas and
data analysis.
A project may involve multiple
procedures bound by a single
protocol. A procedure may
involve one or more assays.
Assay Analytical test that determines a
range of values (preferably
quantitative) for one or more
biological or behavioral
manifestations (traits).
A procedure may involve multiple
assays. An assay quantiﬁes one
or more traits.
Trait Biological or behavioral manifes-
tation of an individual that can
be measured, quantiﬁed or
scientiﬁcally categorized. A trait
is a product of an organism’s
genome, its natural history (e.g.
age), its environmental history
(e.g. fostered pup) and
controlled experimental
perturbations (e.g. high-fat
diet); when a trait is quantiﬁed
for an individual or strain, it is
called a characteristic
(or parameter).
An assay may quantify one or
more traits, and a trait may be
deconstructed into component
traits; a phenotvpe is deter-
mined by one or more traits.
When a trait is measured on a particular set
of individuals as part of a speciﬁc scientiﬁc
investigation (MPD project), the resulting
set of data points is collectively called an
MPD measurement.
MPD Measurement Collection of data points that
measure a trait in individuals of
a population; measurement
values span the range of
biological possibilities for that
population, gathered as part of
a particular scientiﬁc
investigation (MPD project)
which follows a deﬁned
procedure and well-controlled
assay.
An MPD measurement quantiﬁes
(or otherwise deﬁnes) one trait.
There may be multiple. MPD
measurements per project. MPD
measurements are the unit of
analysis (by strain and sex).
Each measurement is annotated
and has a set of attributes or is
otherwise linked to essential
information, such as:
 Accession ID
 Variable name
 Project symbol
 Protocol [procedure(s)]
 Short description
 Tag for baseline/control/intervention
 Units
 Strains and sex tested
 Sample sizes
 Age of mice
 Data type
 Classiﬁcation annotations
 Supplemental information
For example, a protocol might describe multi-system testing
for a panel of inbred strains, which would require the
description of multiple procedures, one of which might be
hematology. The procedure ‘hematology’ involves multiple
assays, including hematocrit and complete blood count
(CBC). The CBC is an assay that measures multiple traits
(WBC, RBC, etc). RBC is a quantiﬁable trait. The values
from an assay (data points) are collectively called an MPD
measurement.
It should be noted that a trait may be measured multiple times. For example
RBC could be measured in more than one study or measured at multiple ages
within a single study. Because one or more conditions of testing are diﬀerent
each time a trait is quantiﬁed for a population, the measurement receives a
unique name, accession number and other attributes (above). Some redundancy
in testing is encouraged for validation purposes because test conditions are rarely
completely identical when animal age, environment and protocol nuances are
considered.
D722 Nucleic Acids Research, 2009, Vol. 37, Databaseissuethe service of updating SNP locations when the mouse
genome reference assembly is updated, and MPD mirrors
these updates when they become available. MPD does not
store ﬂanking sequences or other lower-level trace infor-
mation, but we maintain links to NCBI dbSNP and other
resources holding this data. MPD SNP tools for retrieval
and analysis are illustrated in Figure 2.
Newphenotype strainsurvey dataand functionality
Coat color has been a classic model for many studies in
mouse genetics. Since our last NAR update, photographs
of 60 strains have been made publicly available (Figure 3),
with many strains having a composite of up to four diﬀer-
ent photos. In addition to coat color, there are new
Figure 1. MPD Toolbox. Screenshot of MPD analysis tools, grouped by function: strain proﬁling (identifying mouse models with speciﬁc char-
acteristics), measurement displays, correlations, and other actions. Some of our new tools are featured elsewhere: side-by-side plot and color-grid are
shown in Figure 5, the overlaid-data-points plot in Figures 4 and 6. Try the interactive Tool Demo from the MPD homepage or go to http://
phenome.jax.org/phenome/trytools.
Table 2. SNAPSHOT of Selected MPD Content
Aging blood chemistry  hematology  survival curves  urinalysis
Appearance coat color
Behavior activity  alcohol  anxiety  exploratory  learning and memory  stress reactivity  wildness
Blood chemistry electrolytes  glucose  proteins (enzymes, hormones)
Blood hematology CBC  coagulation  red cell parameters
Blood lipids cholesterol  fatty acids  phospholipid  triglycerides
Body composition fat  fat pads  lean
Body weight & size length  weight  growth curves
Bone geometry  bone mineral content  strength  physiology
Brain morphology  physiology and function
Cancer metastatic progression  tumor growth  tumor histopathology
Cardiovascular blood pressure  ECG  heart rate  organ weight  athersclerosis (aorta fatty-streak lesions)
Drinking preference alcohol  salt solutions
Ear hearing  tympanometry  acoustic startle response  morphology (length)
Endocrine adrenal  hormones
Eye morphology  vision  degeneration
Immunity H2 haplotype  thymus  spleen  peripheral blood lymphocytes
Infectious disease Bacillus anthracis  pathogen-accelerated athersclerosis
Kidney urinalysis  metrics  pathology
Liver and gallbladder function  morphology  pathology (gallstones)
Metabolism activity  energy (intake, production)  food intake  water intake
Muscle skeletal (weight, area)  function (grip strength)
Nervous system autonomic function  neuromuscular function  sensorimotor function
Neurosensory hearing  nociception  prepulse inhibition  vision
Reproduction assisted reproduction technologies  colony reproductive performance
Respiratory lung capacity  allergen-induced inﬂammation
Nucleic Acids Research, 2009,Vol. 37,Database issue D723postings of quantitative measurements that can be classi-
ﬁed as baseline strain surveys, longitudinal aging data and
controlled intervention studies. New data highlights
include studies of bone density, chemically-induced tumor-
igenesis, assisted reproduction, anxiety and exploratory
behavior, vision and eye morphology (for example, see
Figure 4). In addition to inbred strains, data have been
added for chromosome substitution panels and an eight-
way F1 cross panel (see a list of selected projects and par-
ticipants released since our last NAR update in Table 3).
Several phenotype analysis tools have been improved or
developed for better visualization and pattern recognition
(see Figure 5 for examples and details). Of particular note
is a new tool that helps users link phenotype and genotype
(see ‘Find Genomic Regions’ below).
The number of MPD measurements has grown substan-
tially, and we do not expect this trend to wane. To improve
browsing and search capabilities, we have reﬁned our mea-
surement classiﬁcation scheme to present measurement
listings in a more compact and readable way by grouping
measurements with common metadata, for example mea-
surements in a time or dose series are grouped together
conserving space and eliminating the redundancy of
repeated text (see example in Figure 6). In addition, we
have split out ‘intervention’ and ‘age’ from the category
hierarchy which simpliﬁes the classiﬁcation scheme further
and makes it easier on the eye to browse lists of measure-
ments. In some situations, listing measurements without
groupings is helpful, so we have retained this option for
users (see Figure 6 comparing these options).
New genotype (SNP) dataand functionality
We have made various incremental improvements to the
MPD SNP interface such as adding a SNP wizard
Figure 2. MPD SNP interface tools for retrieval and ﬁltering SNPs. SNPs may be retrieved by gene symbol or genomic location (left panel), or by
more complex criteria. A SNP wizard (top right) has been added to assist users, showing possible options for each retrieval method. Users must select
the optimal SNP dataset for their particular research application (see text for details). MPD provides information about each dataset to facilitate the
process. To narrow SNP results as much as possible, options for additional criteria are oﬀered (right panel), such as various ﬁltering modes or by
annotations (Ensembl, NCBI, MGI). An option to set the conﬁdence interval for imputed SNPs is provided for the CGD SNP dataset (see text for
more details and Figure 7).
D724 Nucleic Acids Research, 2009, Vol. 37, Databaseissueinterface and oﬀering more ﬂexible polymorphism ﬁltering
options. New SNP data from several sources have been
added recently, including a 12000-location set for 43
strains (Merck-Rosetta) (11) and mitochondrial character-
ization of 22 strains (University of Porto, Portugal) (12).
The largest new addition is a dataset from the Center for
Genome Dynamics (CGD; http://cgd.jax.org) containing
a mixture of actual and mathematically imputed allele
calls, covering 7.8+million genomic locations for 74
strains, built by merging data from a number of public
data sources and then applying a hidden Markov model
algorithm to impute calls that are missing, and attaching a
conﬁdence level probability value to each imputed call
(13). After importing and processing this dataset, we
found that 78% of the SNPs are imputed, and of those,
72% have a conﬁdence level of 0.9 or higher, while 86%
have a conﬁdence level of 0.6 or higher. MPD supports
queries on this imputed dataset where data are listed based
on a speciﬁed minimum conﬁdence level threshold, for
example ‘show only actual calls’ or ‘show only imputed
calls with conﬁdence level of 0.9 or higher’ (the right panel
of Figure 2 shows this option).
A new exploratory SNP-based tool (called ‘Find
Genomic Regions’) has been developed based on the con-
cept of identity by decent (IBD) whereby two strains or
strain sets can be compared across the entire mouse
genome, to ﬁnd regions where the two strain sets diﬀer
the most. We make the assumption that phenotypic diﬀer-
ences reﬂect genotypic diﬀerences and that diﬀerences in a
causative element (gene or regulatory region) are present
in ancestral variation and are not due to recent mutations.
This tool is based on SNP data from several large datasets
(Perlegen, Broad, Celera) which together cover 8+ million
genomic locations for 16 strains (14–16). This tool can be
used in concert with strain survey data to locate genomic
regions that may have an eﬀect on a given phenotype
(see example in Figure 7). This tool operates not by tabu-
lating individual SNP locations (which would take much
too long for a web-based tool) but rather by scanning an
intermediate ﬁle that has been produced in advance,
Figure 3. Mouse strain coat color and appearance. Sixty strains have
been professionally photographed under standardized conditions
(lighting, background, etc.). Four strains are shown here to illustrate
the wide range of phenotypes found in laboratory strains for coat color
and appearance. DBA/2J is one of the oldest inbred strains in existence.
BTBR T
+tf/J, an inbred strain developed more recently, has a severe
defect in corpus collosum development and exhibits extreme behavioral
phenotypes. JF1/Ms, a wild-derived inbred strain from Japan (10), has
congenital eye abnormalities (Figure 4) and has remarkably high per-
cent body fat although its total body weight is relatively low compared
to other strains; and B6.Cg-A
y/J is a congenic strain that exhibits
severe obesity-related phenotypes. MPD contains data for inbred
strains and their derivatives, such as congenic, consomic and recombi-
nant inbred strains. Photographs by Stanton Short, The Jackson
Laboratory.
Figure 4. Retinal degeneration. Forty inbred strains were examined for
eye abnormalities (retina, cornea, lens, iris). Twenty-ﬁve percent of the
strains exhibit retinal degeneration by 6–7 weeks of age. This study
underscores the importance of using strain characteristics data to
choose optimal strains for testing. An investigator using a behavioral
apparatus that uses visual cues for scoring would not choose JF1/Ms
for the study. Without knowing that JF1 has severe vision problems,
the investigator might incorrectly conclude that JF1 is unintelligent,
anxious or lethargic. Data from Hawes1 MPD:267 (2008).
Nucleic Acids Research, 2009,Vol. 37,Database issue D725T
a
b
l
e
3
.
S
N
A
P
S
H
O
T
o
f
s
e
l
e
c
t
e
d
M
P
D
p
r
o
j
e
c
t
s
a
d
d
e
d
s
i
n
c
e
l
a
s
t
N
A
R
r
e
p
o
r
t
i
n
g
C
r
a
b
b
e
J
C
O
r
e
g
o
n
H
e
a
l
t
h
&
S
c
i
e
n
c
e
U
n
i
v
e
r
s
i
t
y
T
e
s
t
i
n
g
t
h
e
e
ﬀ
e
c
t
s
o
f
a
l
c
o
h
o
l
b
y
q
u
a
n
t
i
t
a
t
i
n
g
m
o
t
o
r
i
n
c
o
o
r
d
i
n
a
t
i
o
n
u
s
i
n
g
t
h
e
p
a
r
a
l
l
e
l
r
o
d
ﬂ
o
o
r
a
p
p
a
r
a
t
u
s
M
e
t
t
e
n
P
,
C
r
a
b
b
e
J
C
O
r
e
g
o
n
H
e
a
l
t
h
&
S
c
i
e
n
c
e
U
n
i
v
e
r
s
i
t
y
E
t
h
a
n
o
l
-
i
n
d
u
c
e
d
i
n
t
o
x
c
a
t
i
o
n
a
n
d
w
i
t
h
d
r
a
w
a
l
s
e
v
e
r
i
t
y
F
i
n
n
D
A
,
M
u
r
i
l
l
o
A
,
Y
o
n
e
y
a
m
a
N
,
C
r
a
b
b
e
J
C
O
r
e
g
o
n
H
e
a
l
t
h
&
S
c
i
e
n
c
e
U
n
i
v
e
r
s
i
t
y
V
o
l
u
n
t
a
r
y
e
t
h
a
n
o
l
c
o
n
s
u
m
p
t
i
o
n
i
n
2
2
i
n
b
r
e
d
s
t
r
a
i
n
s
R
i
c
h
ﬁ
e
l
d
E
K
,
M
h
y
r
e
T
R
,
C
o
r
y
-
S
l
e
c
h
t
a
D
A
,
T
h
i
r
u
c
h
e
l
v
a
m
M
,
C
h
e
s
l
e
r
E
J
E
O
H
S
I
;
U
n
i
v
e
r
s
i
t
y
o
f
R
o
c
h
e
s
t
e
r
M
e
d
i
c
a
l
C
e
n
t
e
r
B
e
h
a
v
i
o
r
a
l
,
n
e
u
r
o
c
h
e
m
i
c
a
l
,
n
e
u
r
o
a
n
a
t
o
m
i
c
a
l
,
a
n
d
n
e
u
r
o
t
o
x
i
c
o
l
o
g
i
c
a
l
c
h
a
r
a
c
t
e
r
i
z
a
t
i
o
n
o
f
t
h
e
m
i
d
b
r
a
i
n
d
o
p
a
m
i
n
e
s
y
s
t
e
m
B
r
o
w
n
R
E
,
S
c
h
e
l
l
i
n
c
k
H
M
,
G
u
n
n
R
K
,
W
o
n
g
A
A
,
O
’
L
e
a
r
y
T
P
D
a
l
h
o
u
s
i
e
U
n
i
v
e
r
s
i
t
y
(
C
A
N
A
D
A
)
A
n
x
i
e
t
y
,
e
x
p
l
o
r
a
t
o
r
y
b
e
h
a
v
i
o
r
a
n
d
m
o
t
o
r
a
c
t
i
v
i
t
y
;
V
i
s
u
a
l
a
b
i
l
i
t
y
a
n
d
s
p
a
t
i
a
l
,
m
o
t
o
r
a
n
d
o
l
f
a
c
t
o
r
y
l
e
a
r
n
i
n
g
a
n
d
m
e
m
o
r
y
G
e
r
s
h
e
n
f
e
l
d
H
K
U
n
i
v
e
r
s
i
t
y
o
f
T
e
x
a
s
–
S
o
u
t
h
w
e
s
t
e
r
n
I
m
i
p
r
a
m
i
n
e
r
e
s
p
o
n
s
e
a
n
d
t
a
i
l
s
u
s
p
e
n
s
i
o
n
t
e
s
t
G
r
a
u
b
e
r
t
T
A
,
W
a
t
t
e
r
s
J
W
,
M
c
L
e
o
d
H
W
a
s
h
i
n
g
t
o
n
U
n
i
v
e
r
s
i
t
y
S
c
h
o
o
l
o
f
M
e
d
i
c
i
n
e
E
N
U
-
i
n
d
u
c
e
d
t
u
m
o
r
i
g
e
n
e
s
i
s
C
h
u
r
c
h
i
l
l
G
A
,
B
a
l
d
w
i
n
C
J
A
X
;
B
o
s
t
o
n
U
n
i
v
e
r
s
i
t
y
B
o
n
e
c
h
a
r
a
c
t
e
r
i
s
t
i
c
s
a
n
d
b
o
d
y
c
o
m
p
o
s
i
t
i
o
n
o
f
a
n
8
-
w
a
y
d
i
a
l
l
e
l
e
c
r
o
s
s
D
o
n
a
h
u
e
L
,
B
e
a
m
e
r
W
G
,
B
o
g
u
e
M
A
,
C
h
u
r
c
h
i
l
l
G
A
J
A
X
M
o
d
e
l
s
o
f
s
k
e
l
e
t
a
l
g
e
o
m
e
t
r
y
a
n
d
b
o
n
e
s
t
r
e
n
g
t
h
D
o
n
a
h
u
e
L
J
A
X
B
o
n
e
m
i
n
e
r
a
l
d
e
n
s
i
t
y
,
b
o
d
y
c
o
m
p
o
s
i
t
i
o
n
,
a
n
d
c
r
a
n
i
o
f
a
c
i
a
l
c
h
a
r
a
c
t
e
r
i
z
a
t
i
o
n
H
a
w
e
s
N
L
,
C
h
a
n
g
B
,
D
a
v
i
s
s
o
n
M
T
J
A
X
M
o
r
p
h
o
l
o
g
i
c
a
l
e
x
a
m
i
n
a
t
i
o
n
o
f
t
h
e
e
y
e
i
n
4
1
i
n
b
r
e
d
s
t
r
a
i
n
s
o
f
m
i
c
e
C
h
a
n
g
B
,
H
a
w
e
s
N
L
,
D
a
v
i
s
s
o
n
M
T
J
A
X
E
l
e
c
t
r
o
r
e
t
i
n
o
g
r
a
m
(
E
R
G
)
e
x
a
m
i
n
a
t
i
o
n
i
n
1
7
i
n
b
r
e
d
s
t
r
a
i
n
s
o
f
m
i
c
e
S
u
g
i
y
a
m
a
F
,
T
s
u
k
a
h
a
r
a
C
,
P
a
i
g
e
n
B
U
n
i
v
e
r
s
i
t
y
o
f
T
s
u
k
u
b
a
(
J
A
P
A
N
)
;
J
A
X
B
l
o
o
d
p
r
e
s
s
u
r
e
f
o
r
2
5
s
t
r
a
i
n
s
T
o
m
a
s
i
n
i
-
J
o
h
a
n
s
s
o
n
B
R
,
M
o
s
h
e
r
D
F
U
n
i
v
e
r
s
i
t
y
o
f
W
i
s
c
o
n
s
i
n
C
o
n
c
e
n
t
r
a
t
i
o
n
o
f
ﬁ
b
r
o
n
e
c
t
i
n
i
n
m
o
u
s
e
p
l
a
s
m
a
P
e
t
e
r
s
L
L
J
A
X
A
g
i
n
g
s
t
u
d
y
:
B
l
o
o
d
h
e
m
a
t
o
l
o
g
y
Y
u
a
n
R
J
A
X
A
g
i
n
g
s
t
u
d
y
:
B
l
o
o
d
c
h
e
m
i
s
t
r
y
Y
u
a
n
R
,
R
o
s
e
n
C
J
,
B
e
a
m
e
r
W
G
J
A
X
A
g
i
n
g
s
t
u
d
y
:
I
G
F
-
1
a
n
d
b
o
d
y
w
e
i
g
h
t
K
o
r
s
t
a
n
j
e
R
J
A
X
A
g
i
n
g
s
t
u
d
y
:
U
r
i
n
e
a
l
b
u
m
i
n
a
n
d
c
r
e
a
t
i
n
i
n
e
S
e
b
u
r
n
K
L
,
X
i
n
g
S
,
B
u
r
g
e
s
s
R
W
J
A
X
A
g
i
n
g
s
t
u
d
y
:
G
r
i
p
s
t
r
e
n
g
t
h
a
n
d
g
a
i
t
a
n
a
l
y
s
i
s
T
a
f
t
R
A
,
B
y
e
r
s
S
L
J
A
X
A
s
s
i
s
t
e
d
r
e
p
r
o
d
u
c
t
i
v
e
t
e
c
h
n
o
l
o
g
i
e
s
(
A
R
T
s
)
J
A
X
P
h
e
n
o
t
y
p
i
n
g
S
e
r
v
i
c
e
s
J
A
X
C
o
m
p
r
e
h
e
n
s
i
v
e
s
u
r
v
e
y
o
f
1
1
i
n
b
r
e
d
s
t
r
a
i
n
s
S
v
e
n
s
o
n
K
L
,
F
o
r
e
j
t
J
,
D
o
n
a
h
u
e
L
,
P
a
i
g
e
n
B
J
A
X
M
u
l
t
i
-
s
y
s
t
e
m
a
n
a
l
y
s
i
s
o
f
m
o
u
s
e
p
h
y
s
i
o
l
o
g
y
,
C
5
7
B
L
/
6
J
-
C
h
r
#
P
W
D
c
h
r
o
m
o
s
o
m
e
s
u
b
s
t
i
t
u
t
i
o
n
s
t
r
a
i
n
p
a
n
e
l
N
a
d
e
a
u
J
H
,
H
i
l
l
A
E
C
a
s
e
W
e
s
t
e
r
n
R
e
s
e
r
v
e
U
n
i
v
e
r
s
i
t
y
S
c
h
o
o
l
o
f
M
e
d
i
c
i
n
e
C
5
7
B
L
/
6
J
-
C
h
r
#
A
/
J
c
h
r
o
m
o
s
o
m
e
s
u
b
s
t
i
t
u
t
i
o
n
s
t
r
a
i
n
p
a
n
e
l
:
D
i
e
t
-
I
n
d
u
c
e
d
O
b
e
s
i
t
y
L
a
k
e
J
,
D
o
n
a
h
u
e
L
,
D
a
v
i
s
s
o
n
M
T
J
A
X
C
o
m
p
r
e
h
e
n
s
i
v
e
p
h
e
n
o
t
y
p
e
s
u
r
v
e
y
,
C
5
7
B
L
/
6
J
-
C
h
r
#
A
/
N
a
J
c
h
r
o
m
o
s
o
m
e
s
u
b
s
t
i
t
u
t
i
o
n
s
t
r
a
i
n
p
a
n
e
l
P
a
l
m
e
r
A
,
P
o
n
d
e
r
C
A
,
M
u
n
o
z
M
,
G
i
l
l
i
a
m
C
U
n
i
v
e
r
s
i
t
y
o
f
C
h
i
c
a
g
o
I
n
n
a
t
e
a
n
x
i
e
t
y
-
l
i
k
e
b
e
h
a
v
i
o
r
a
n
d
f
e
a
r
c
o
n
d
i
t
i
o
n
i
n
g
i
n
C
5
7
B
L
/
6
J
-
C
h
r
#
A
/
J
c
h
r
o
m
o
s
o
m
e
s
u
b
s
t
i
t
u
t
i
o
n
s
t
r
a
i
n
p
a
n
e
l
D726 Nucleic Acids Research, 2009, Vol. 37, Databaseissuecontaining tabulations of strain diﬀerences for successive
50kb windows.
NewQTL analysis archive
At the request of members of the research community,
MPD has developed an archive of quantitative trait loci
(QTL) analysis datasets. At this writing there are 23 data-
sets available in a variety of subject areas, many associated
with projects that have also contributed inbred strain
survey data to MPD. These QTL studies typically involve
intercross (F2) or backcross (N2) progeny of strains in the
MPD priority list. Currently these data are available in
Excel spreadsheets (R/qtl format), where a spreadsheet
contains phenotypic measurements for each individual in
the population (usually several hundred mice) and their
genotypes (typically based on Mit markers). Linkages to
MPD phenotype categories are maintained to optimize
search capabilities, and links to MGI are maintained for
connectivity to other databases. The primary purpose of
the QTL archive is to provide a public repository for these
datasets so that investigators can easily ﬁnd and download
them for custom analyses, e.g. combined cross analysis to
reduce QTL intervals to a more manageable size for sub-
sequent gene testing and validation. We plan to add QTL
analysis tools in the near future, including interactive
QTL maps.
HIGH LEVEL OVERVIEW OF IMPLEMENTATION
All public access to MPD is via our web site. MPD runs
on a Solaris (Unix) computer system and is implemented
using an open source software platform that includes rela-
tional database, web presentation scripting, and integrated
graphical data plotting components. Apache web server
software serves our web pages using a CGI method, and
web ‘cookies’ are utilized to manage user preferences and
item collections. Some custom-written programs in the ‘C’
language are invoked for compute-intensive tasks such as
computation of statistics and correlations, and for SNP
data display. We have a URL interface that web site devel-
opers can use to build links to speciﬁc MPD data views
(visit our web site and search on ‘URL’).
The database has 70 data tables, including 6 containing
mouse biometric data, 30 for SNP data, 17 catalogs and
dictionaries, and 8 of various internal and external map-
pings (our detailed data model can be viewed by visiting
our web site and searching on ‘schema’). Data are typi-
cally contributed using Excel spreadsheets transmitted as
Figure 5. New phenotype tools for strain proﬁling and identifying
important new mouse models for research. The Jackson Aging Center
is in the process of testing 32 inbred strains for a wide variety of
phenotypic traits at 6, 12, 18 and 24 months of age. A new tool has
been developed to visualize aging trends graphically (above). In this
example, three time points for thyroxine (T4) are shown for each
strain. Such a tool is critical for understanding aging processes which
are not always linear over time. This tool helped identify several com-
plex phenotypes which would not have been discovered if examining
only one time point. Another new tool useful for identifying mouse
models in shown in the lower panel. The color grid tool is based on
the heat map concept using Z-scores. Strain names are listed on the
left, measurement numbers are shown along the top (1–6) which are
fully deﬁned below the grid when viewing online. Shades of red indicate
those measurements that are above the overall mean and blue indicates
those that are below. Intensity of color tracks with severity, where the
more intense colors are the most extreme. More new tools are featured
in Figure 6. Data (upper) from Yuan3 MPD:244 (2008); (lower)
Churchill1 MPD:171 (2004).
Nucleic Acids Research, 2009,Vol. 37,Database issue D727email attachments, and all database updates are made by
staﬀ via interactive web tools or direct table updates to
our development node. MPD’s production node is then
refreshed from the development node as needed. There is
no situation where the database is directly updated by
non-staﬀ users.
AN INVITATION TO INVESTIGATORS
AND FUTURE MPD DIRECTIONS
Data in all subject areas with potential relevance to
translational research towards improvement of human
health are of considerable importance. Although many
phenotypic domains are currently represented in MPD,
the acquisition of new data is open-ended with the goal
of collecting data on a broader scope (and in some cases
to a deeper level for phenotypes needing more granularity)
as well as collecting data generated from new, more
sophisticated phenotyping technologies. To expand the
scope and maximize the utility of MPD, members of the
global scientiﬁc community are invited to contribute
their strain survey data or join us in a coordinated eﬀort
to seek funding that will support systematic strain surveys.
It is this spirit of collaboration that has shaped MPD and
made it an important community resource and that
will continue to guide the future growth and development
of MPD.
Researchers interested in contributing data to MPD or
in collaborating on new phenotyping projects should con-
tact us at phenome@jax.org. Data submission guidelines
are accessible through the MPD homepage ‘How to con-
tribute data’.
MPD provides user support through online documenta-
tion and via email (phenome@jax.org). PHENOME-
LIST is a moderated electronic bulletin board http://phe-
nome.jax.org/phenome/list.html. We welcome user input
and suggestions. Our Suggestion Box is accessible from
most every MPD page (footer). Suggestions or comments
can be submitted anonymously.
Figure 6. MPD measurement categories and using metadata to organize displays. When new MPD measurements are accessioned, they are classiﬁed
based on the trait measured and experimental context. In this example, when a set of data containing three triglyceride measurements was submitted
to MPD (projects are given a symbol, e.g. Albers1), each measurement was annotated (metadata) to reﬂect the population tested, the experimental
methods (baseline vs. intervention of high fat diet for 6 weeks), and biological parameters (age). The lower panel shows the older MPD display where
the metadata is included in every row. The middle panel shows the same measurements and illustrates our new method of displaying measurements
based on common metadata. Although redundancy is diminished, each measurement still retains all its originally annotated metadata which is visible
in other website views. The grouping display is now the default when browsing by category, but users may toggle between viewing options. The new
classiﬁcation scheme is amenable to adding comparison views. In this case, a plot is generated that shows a diet-eﬀect comparison (click on link at
green arrow) showing all three measurements in a single plot. Blue arrow: ‘?’ is a quick link to the protocol and the shopping cart icon is for ﬂagging
measurements to create customized datasets, an advanced MPD feature not discussed here. The upper panel illustrates a new feature to show
consensus views of related measurements across multiple projects (red arrow). The thumbnail view shows baseline triglyceride levels from four
diﬀerent MPD projects. Strain sets may not overlap 100% as shown here where some strains were tested by only two projects and other strains were
tested by all four projects. Albers1 MPD:8 (1999).
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For general citation of MPD, this article may be used. In
addition, the following citation format may be used when
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Investigator(s) name (year project posted) Project title.
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APPENDIX
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Diseases
National Institute on Drug Abuse
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National Institute of Neurological Disorders and Stroke
American Health Assistance Foundation
American Heart Association
American Liver Foundation
American Physiological Society
Andrew Mellon Foundation
AstraZeneca
Aventis
BD Biosciences
Bristol-Myers Squibb
Burroughs Wellcome Fund
Canadian Institutes for Health Research
Centre National de la Recherche Scientiﬁque (CNRS)
Commonwealth of Pennsylvania Health Research
Formula Grant
Council for Nail Research
Department of the Army
Department of Defense
Department of Veterans Aﬀairs
Dermatology Foundation
Deutsche Forschungsgemeinschaft
Ellison Medical Foundation
Fonds pour la Formation de Chercheurs et l’Aide a la
Recherche of Quebec
Foundation Fighting Blindness
GlaxoSmithKline
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The Jackson Laboratory
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Japanese Ministry of Education, Science, Sport, and
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Knoll Pharmaceutical
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Merck Genome Research Institute
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Ministere de la Recherche et de la Technologie
National Alopecia Areata Foundation
National Health and Medical Research Council of
Australia
National Science Foundation
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